Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 2 minute read Pharma Industry News Sol-Gel acquires Gorlin syndrome drug candidate Patidegib from PellePharm Sol-Gel Technologies, an Israel-based dermatology company, has acquired patidegib, a Gorlin syndrome drug candidate in phase 3 development,… byRaghuram KadariJanuary 31, 2023